TRPV1 is a component of the atrial natriuretic signaling complex, and using orally delivered antagonists, presents a valid therapeutic target in the longitudinal reversal and treatment of cardiac hypertrophy and heart failure-Reference-Cited by-同舟云学术

TRPV1 is a component of the atrial natriuretic signaling complex, and using orally delivered antagonists, presents a valid therapeutic target in the longitudinal reversal and treatment of cardiac hypertrophy and heart failure

Published:2018-12-12 Issue:1 Volume:13 Page:1-16
ISSN:1933-6950
Container-title:Channels
language:en
Short-container-title:Channels

Author:

Horton Jaime S.¹,Shiraishi Takuya²,Alfulaij Naghum¹^ORCID,Small-Howard Andrea L.³,Turner Helen C.⁴⁵⁶,Kurokawa Tatsuki⁷²,Mori Yasuo²,Stokes Alexander J.¹⁴⁵⁶⁸^ORCID

Affiliation:

1. Laboratory of Experimental Medicine, John A. Burns School of Medicine, University of Hawaii, Honolulu, HI 96813 USA

2. Laboratory of Molecular Biology, Department of Synthetic Chemistry and Biological Chemistry, Graduate School of Engineering, Kyoto University, Nishikyo-ku, Kyoto, 615-8510, Japan

3. GB Sciences Inc., 3550 W Teco Ave, Las Vegas, NV 89118 USA

4. Department of Cell and Molecular Biology, John A. Burns School of Medicine, University of Hawaii, Honolulu, HI 96813 USA

5. Queen’s Medical Center, Punchbowl Street, Honolulu, HI, USA

6. Division of Natural Sciences and Mathematics, Chaminade University, Honolulu, HI USA

7. Department of Pathophysiology Faculty of Medicine, Oita University 1-1 Idaigaoka, Hasama, Yufu, Oita 879-5593, Japan

8. Department of Molecular Biosciences and Bioengineering, University of Hawaii, Honolulu, HI 96822 USA

Funder

Hawaii Community Foundation

NIH COBRE

National Institute of General Medical Sciences (US)

Publisher

Informa UK Limited

Subject

Biochemistry,Biophysics

Link

https://www.tandfonline.com/doi/pdf/10.1080/19336950.2018.1547611

Reference68 articles.

1. Circulation : Clinical Summaries

2. Heart Disease and Stroke Statistics—2011 Update

3. Executive Summary: Heart Disease and Stroke Statistics—2010 Update

4. Cardiopulmonary exercise testing in congestive heart failure

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transient receptor potential cation channel subfamily V member 1 (TRPV1) targeted PET imaging;Japanese Journal of Clinical Oncology;2024-01-20

2. TRP channels in cardiovascular disease;TRP Channels as Therapeutic Targets;2024

3. Transient receptor potential vanilloid type 1: cardioprotective effects in diabetic models;Channels;2023-11-20

4. New Therapeutics for Heart Failure: Focusing on cGMP Signaling;International Journal of Molecular Sciences;2023-08-16

5. Role of Known Transient Receptor Potential Vanilloid Channels in Modulating Cardiac Mechanobiology;Frontiers in Physiology;2021-10-15